Glucosio Baxter S.P.A. (Glucose Monohydrate)

Glucosio Baxter is indicated for clinical situations where an immediate source of carbohydrate is required.

• Parenteral nutrition as part of total nutrient admixtures for patients unable to receive enteral feeding.
• Treatment of acute hypoglycemia in emergency or perioperative settings.
• Support during prolonged fasting or pre‑operative fasting when oral intake is not possible.
• Dilution and compatible mixing with other intravenous medications for fluid replacement.
• Management of glucose requirements in critically ill patients under intensive care monitoring.

Glucosio Baxter may be associated with infusion‑related reactions, although many patients tolerate the solution without notable events.

Common

• Local irritation at the injection site
• Transient hyperglycemia
• Mild electrolyte shifts (e.g., sodium, potassium)
• Nausea or mild abdominal discomfort

Serious

• Severe hyperglycemia leading to osmotic diuresis
• Allergic or anaphylactic reaction to the solution components
• Fluid overload causing pulmonary edema
• Metabolic acidosis in susceptible patients

When prescribing Glucosio Baxter, clinicians should evaluate patient‑specific factors and monitor for potential complications.

• Assess blood glucose levels before and during infusion to avoid excessive hyperglycemia.
• Use caution in patients with diabetes mellitus, renal impairment, or heart failure.
• Adjust infusion rate in neonates, infants, and pediatric patients due to different metabolic rates.
• Monitor fluid balance and electrolytes, especially sodium and potassium, during prolonged administration.
• Avoid rapid bolus administration unless clinically indicated.
• Verify compatibility with other intravenous solutions to prevent precipitation.
• Document any adverse reactions in the patient’s medical record.

Glucosio Baxter can interact with other agents administered intravenously or affect systemic metabolic pathways.

Avoid

• Concurrent high‑dose insulin infusions without glucose monitoring, which may precipitate severe hypoglycemia.
• Co‑administration with other hypertonic glucose solutions, increasing risk of hyperosmolar complications.
• Use with potassium‑rich solutions without electrolyte monitoring, risking hyperkalemia.

Use with caution

• Simultaneous administration of diuretics that may alter fluid and electrolyte status.
• Concurrent use of corticosteroids, which can raise blood glucose levels.
• Combination with beta‑adrenergic agonists that may affect glucose metabolism.